Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration

Published on Feb 22, 2021in Acta neuropathologica communications6.27
· DOI :10.1186/S40478-021-01124-7
Atsuhito Uneda8
Estimated H-index: 8
(Okayama University),
Kazuhiko Kurozumi23
Estimated H-index: 23
(Okayama University)
+ 12 AuthorsIsao Date58
Estimated H-index: 58
(Okayama University)
Sources
Abstract
Glioblastoma (GBM) is the most lethal primary brain tumor characterized by significant cellular heterogeneity, namely tumor cells, including GBM stem-like cells (GSCs) and differentiated GBM cells (DGCs), and non-tumor cells such as endothelial cells, vascular pericytes, macrophages, and other types of immune cells. GSCs are essential to drive tumor progression, whereas the biological roles of DGCs are largely unknown. In this study, we focused on the roles of DGCs in the tumor microenvironment. To this end, we extracted DGC-specific signature genes from transcriptomic profiles of matched pairs of in vitro GSC and DGC models. By evaluating the DGC signature using single cell data, we confirmed the presence of cell subpopulations emulated by in vitro culture models within a primary tumor. The DGC signature was correlated with the mesenchymal subtype and a poor prognosis in large GBM cohorts such as The Cancer Genome Atlas and Ivy Glioblastoma Atlas Project. In silico signaling pathway analysis suggested a role of DGCs in macrophage infiltration. Consistent with in silico findings, in vitro DGC models promoted macrophage migration. In vivo, coimplantation of DGCs and GSCs reduced the survival of tumor xenograft-bearing mice and increased macrophage infiltration into tumor tissue compared with transplantation of GSCs alone. DGCs exhibited a significant increase in YAP/TAZ/TEAD activity compared with GSCs. CCN1, a transcriptional target of YAP/TAZ, was selected from the DGC signature as a candidate secreted protein involved in macrophage recruitment. In fact, CCN1 was secreted abundantly from DGCs, but not GSCs. DGCs promoted macrophage migration in vitro and macrophage infiltration into tumor tissue in vivo through secretion of CCN1. Collectively, these results demonstrate that DGCs contribute to GSC-dependent tumor progression by shaping a mesenchymal microenvironment via CCN1-mediated macrophage infiltration. This study provides new insight into the complex GBM microenvironment consisting of heterogeneous cells.
📖 Papers frequently viewed together
8 Authors (You Zhai, ..., Wei Zhang)
3 Citations
1 Citations
20126.02Stem Cells
55 Citations
References64
Newest
#1Weiwei Tao (Cleveland Clinic)H-Index: 13
#2Chengwei Chu (Cleveland Clinic)H-Index: 2
Last. Shideng Bao (Case Western Reserve University)H-Index: 32
view all 18 authors...
The interplay between glioma stem cells (GSCs) and the tumor microenvironment plays crucial roles in promoting malignant growth of glioblastoma (GBM), the most lethal brain tumor. However, the molecular mechanisms underlying this crosstalk are incompletely understood. Here, we show that GSCs secrete the Wnt‐induced signaling protein 1 (WISP1) to facilitate a pro-tumor microenvironment by promoting the survival of both GSCs and tumor-associated macrophages (TAMs). WISP1 is preferentially expresse...
23 CitationsSource
#1Maojin Yao (UVA: University of Virginia)H-Index: 3
#2P. Britten Ventura (UVA: University of Virginia)H-Index: 1
Last. Hui Zong (UVA: University of Virginia)H-Index: 23
view all 19 authors...
Summary The tumor microenvironment (TME) is critical for tumor progression. However, the establishment and function of the TME remain obscure because of its complex cellular composition. Using a mouse genetic system called mosaic analysis with double markers (MADMs), we delineated TME evolution at single-cell resolution in sonic hedgehog (SHH)-activated medulloblastomas that originate from unipotent granule neuron progenitors in the brain. First, we found that astrocytes within the TME (TuAstroc...
28 CitationsSource
#1Yusuke Tomita (Okayama University)H-Index: 6
#2Kazuhiko Kurozumi (Okayama University)H-Index: 23
Last. Isao Date (Okayama University)H-Index: 58
view all 13 authors...
Anti-vascular endothelial growth factor treatments such as bevacizumab have demonstrated convincing therapeutic advantage in glioblastoma patients. However, bevacizumab has also been reported to induce invasiveness of glioma. In this study, we examined the effects of Rapid Antiangiogenesis Mediated By Oncolytic virus (RAMBO), an oncolytic herpes simplex virus-1 expressing vasculostatin, on bevacizumab-induced glioma invasion. The effect of the combination of RAMBO and bevacizumab in vitro was as...
10 CitationsSource
#1Myo-Hyeon Park (KNU: Kyungpook National University)H-Index: 1
#2Ae kyung Kim (UPR-RP: UPRRP College of Natural Sciences)H-Index: 1
Last. You Mie Lee (UPR-RP: UPRRP College of Natural Sciences)H-Index: 38
view all 16 authors...
: CCN1 (CYR61) stimulates active angiogenesis in various tumours, although the mechanism is largely unknown. Here, we report that CCN1 is a key regulator of endothelial tip cell activity in angiogenesis. Microvessel networks and directional vascular cell migration patterns were deformed in ccn1-knockdown zebrafish embryos. CCN1 activated VEGFR2 and downstream MAPK/PI3K signalling pathways, YAP/TAZ, as well as Rho effector mDia1 to enhance tip cell activity and CCN1 itself. VEGFR2 interacted with...
11 CitationsSource
#1Cyril NeftelH-Index: 6
#2Julie Laffy (Weizmann Institute of Science)H-Index: 1
Last. Mario L. Suvà (Broad Institute)H-Index: 33
view all 58 authors...
Summary Diverse genetic, epigenetic, and developmental programs drive glioblastoma, an incurable and poorly understood tumor, but their precise characterization remains challenging. Here, we use an integrative approach spanning single-cell RNA-sequencing of 28 tumors, bulk genetic and expression analysis of 401 specimens from the The Cancer Genome Atlas (TCGA), functional approaches, and single-cell lineage tracing to derive a unified model of cellular states and genetic diversity in glioblastom...
412 CitationsSource
#1Ryan C. Gimple (UCSD: University of California, San Diego)H-Index: 17
#2Shruti Bhargava (UCSD: University of California, San Diego)H-Index: 7
Last. Jeremy N. Rich (UCSD: University of California, San Diego)H-Index: 111
view all 4 authors...
: Glioblastoma ranks among the most lethal of all human cancers. Glioblastomas display striking cellular heterogeneity, with stem-like glioblastoma stem cells (GSCs) at the apex. Although the original identification of GSCs dates back more than a decade, the purification and characterization of GSCs remains challenging. Despite these challenges, the evidence that GSCs play important roles in tumor growth and response to therapy has grown. Like normal stem cells, GSCs are functionally defined and...
91 CitationsSource
#1J Behnan (KI: Karolinska Institutet)H-Index: 8
#2Gaetano FinocchiaroH-Index: 67
Last. Gabi Hanna (Duke University)H-Index: 15
view all 3 authors...
: The complexity of glioblastoma multiforme, the most common and lethal variant of gliomas, is reflected by cellular and molecular heterogeneity at both the inter- and intra-tumoural levels. Molecular subtyping has arisen in the past two decades as a promising strategy to give better predictions of glioblastoma multiforme evolution, common disease pathways, and rational treatment options. The Cancer Genome Atlas network initially identified four molecular subtypes of glioblastoma multiforme: pro...
101 CitationsSource
#1Sarah Pasquin (UdeM: Université de Montréal)H-Index: 6
#2Véronique Laplante (UdeM: Université de Montréal)H-Index: 3
Last. Jean-François Gauchat (UdeM: Université de Montréal)H-Index: 51
view all 10 authors...
CLCF1 is a neurotrophic and B cell–stimulating factor belonging to the IL-6 family. Mutations in the gene coding for CLCF1 or its secretion partner CRLF1 lead to the development of severe phenotypes, suggesting important nonredundant roles in development, metabolism, and immunity. Although CLCF1 was shown to promote the proliferation of the myeloid cell line M1, its roles on myeloid activation remain underinvestigated. We characterized the effects of CLCF1 on myeloid cells with a focus on monocy...
7 CitationsSource
#1Jun Wei (University of Texas MD Anderson Cancer Center)H-Index: 46
#1Jun Wei (University of Texas MD Anderson Cancer Center)H-Index: 73
Last. Amy B. Heimberger (University of Texas MD Anderson Cancer Center)H-Index: 65
view all 20 authors...
Glioblastoma is highly enriched with macrophages, and osteopontin (OPN) expression levels correlate with glioma grade and the degree of macrophage infiltration; thus, we studied whether OPN plays a crucial role in immune modulation. Quantitative PCR, immunoblotting, and ELISA were used to determine OPN expression. Knockdown of OPN was achieved using complementary siRNA, shRNA, and CRISPR/Cas9 techniques, followed by a series of in vitro functional migration and immunological assays. OPN gene-def...
82 CitationsSource
#1J. Matthew Barnes (UCSF: University of California, San Francisco)H-Index: 12
#2Shelly Kaushik (UCSF: University of California, San Francisco)H-Index: 7
Last. Valerie M. WeaverH-Index: 87
view all 22 authors...
Glioblastoma multiforme (GBMs) are recurrent lethal brain tumours. Recurrent GBMs often exhibit mesenchymal, stem-like phenotypes that could explain their resistance to therapy. Analyses revealed that recurrent GBMs have increased tension and express high levels of glycoproteins that increase the bulkiness of the glycocalyx. Studies showed that a bulky glycocalyx potentiates integrin mechanosignalling and tissue tension and promotes a mesenchymal, stem-like phenotype in GBMs. Gain- and loss-of-f...
42 CitationsSource
Cited By2
Newest
#1Rongsheng Huang (Okayama University)
#2Atsushi Fujimura (Okayama University)H-Index: 13
Last. Atsunori Kamiya (Okayama University)H-Index: 22
view all 9 authors...
Abstract Malignant peripheral nerve sheath tumor (MPNST), a highly malignant tumor that arises in peripheral nerve tissues, is known to be highly resistant to radiation and chemotherapy. Although there are several reports on genetic mutations and epigenetic changes that define the pathogenesis of MPNST, there is insufficient information regarding the microenvironment that contributes to the malignancy of MPNST. In the present study, we demonstrate that adrenaline increases the cancer stem cell p...
Source
Last. Laurence ChoulierH-Index: 21
view all 5 authors...
Glioblastoma (GBM), the most frequent and aggressive glial tumor, is currently treated as first line by the Stupp protocol, which combines, after surgery, radiotherapy and chemotherapy. For recurrent GBM, in absence of standard treatment or available clinical trials, various protocols including cytotoxic drugs and/or bevacizumab are currently applied. Despite these heavy treatments, the mean overall survival of patients is under 18 months. Many clinical studies are underway. Based on clinicaltri...
Source